The greatest increases in methylation in Wnt11, Celsr2 and Adcy3 could indicate future routes of investigation to elucidate the potential of PEA in NASH treatment, especially given their associations with obesity and diabetes [38–41]. The gene discussed is ADCY3; the disease is obesity due to melanocortin 4 receptor deficiency.